When American Firms Turn to the Australian Securities Exchange for Public Offerings
American founders and CFOs often assume that a U.S. exchange is the only viable path to public-company status — but a meaningful number of middle-market businesses have discovered that the Australian Securities Exchange (ASX) offers a legitimate and sometimes more cost-effective alternative. Understanding why requires a close look at the regulatory environment, market culture, and structural realities of each market.
The Case for Looking Outside the United States
A big piece of the reverse takeover/merger world in the United States revolves around sourcing growth opportunities in foreign nations that want to list on a U.S.-based exchange. It's not uncommon at all. It's unfortunate that that's where much of the fraud occurs, but recent regulations, improvement in the companies themselves and some self-filtering by deal-makers has actually helped to improve the offerings of such firms.
It's not surprising that some U.S.-based firms have opted for the same thing: performing their public offering via reverse merger outside of their “motherland.” Australia and London are often two of the most active RM/RTO markets outside the United States. A prime, notable RTO example in Australia is that of Kim Dotcom, the notorious founder of MegaUpload. He recently listed his new startup on the Australian Securities Exchange.
Another recent notable example is the 3D printing company 3D Group. These are certainly notable examples of Australian firms doing great things for the ASX, but what of the likes of Manalto doing the same thing. Many have asked “why?” There are a number of reasons Australia may have a better reputation for RTOs. Here are some thoughts as to why. The larger exchanges (and SEC regulatory scrutiny) in the U.S. provide such a high threshold for entrance, that many legitimate middle-market firms are not incentivized to even list.
The cost (both financial and otherwise) is just too high. That means what's left to go public are the smaller startups with less-lofty prospects and much higher failure rates. Australia, on the other hand, lists many more legitimate, profitable companies in the middle market are listed on an Australian exchange. That means a large market for legit deals surfaces where companies have a price and timing incentive to list and where they're not burdened by the onerousness of Sarbanes-Oxley. I hate to say less manipulators exist in Australia, but data suggests this might be true — even if the Australia-haters point to the fact that the country was started with a group of British criminals — (I hope you're picking up the thick sarcasm there). Perhaps the biggest contributor to the problem is the shear size of the American market, the mechanical ease of getting something up and trading and the potential upside when manipulation does take place. Most of all, the cost, including attorneys, accountants and other consultants is even cheaper when performing an alternative offering in the Australian market.
Perhaps the biggest boon here is that there is less of a tainted image in Australia where reverse mergers provide very legitimate public offerings for a huge host of very legitimate companies. Due to some very infamous RTO cases here in the United States, reverse mergers don't have a very good reputation here compared to other parts of the world. In fact, the legitimacy of such reverse merger deals on the ASX are not nearly as tainted as they are on the Over the Counter exchange here in the United States. Whatever the motivation for performing a reverse merger outside the United States, firms that go about this process without a real solid market and at least some scalable revenues may soon find themselves as one of the casualties strewn across the reverse merger graveyard.
But, if done right, going public on a foreign exchange, especially if a company is trying to save a few coin and some onerous regulation may not be a bad move.
Key Structural Differences: ASX vs. U.S. Exchanges
Before committing to any public-offering path, it helps to map the structural differences side by side.
- Listing thresholds: The ASX has tiered entry tests (profit test and asset test) that many profitable middle-market businesses can satisfy without the scale required for a Nasdaq or NYSE listing.
- Regulatory burden: Sarbanes-Oxley compliance and SEC reporting requirements add substantial ongoing cost. Australian continuous disclosure obligations are rigorous but generally less expensive to administer for smaller issuers.
- Shell quality: A meaningful share of ASX shells are former operating companies with clean balance sheets, which can reduce post-merger cleanup time.
- Investor base: Australia has a deeply retail-oriented investment culture, which can support liquidity for smaller-cap listed companies that would be ignored on U.S. exchanges.
For founders weighing alternative public offerings — including private placements combined with reverse mergers — understanding these structural distinctions is foundational to selecting the right path.
What the Process Looks Like in Practice
A U.S. company pursuing an ASX reverse takeover typically follows a sequence similar to a domestic RTO, but with Australian-specific legal and disclosure requirements layered in.
- Identify and vet the ASX shell: Source a dormant or near-dormant listed entity with a clean capital structure. Australian corporate advisors and stockbrokers specializing in RTOs are the typical intermediaries.
- Negotiate the transaction structure: Terms are usually expressed as a share-swap ratio. The incoming business often ends up holding the majority of the combined entity.
- Lodge an information memorandum: Australian securities law requires substantial disclosure to existing shareholders. This document functions similarly to a U.S. proxy statement.
- Shareholder and regulatory approvals: ASX Listing Rule 11.1 and ASIC oversight govern change-of-activity transactions. Approval timelines vary but are often comparable to a U.S. EDGAR review cycle.
- Re-compliance listing: The shell must re-satisfy ASX listing requirements post-transaction, including minimum spread of shareholders.
Companies that approach this process without a thorough understanding of why securities laws matter — in either jurisdiction — tend to encounter costly delays or, worse, regulatory rejection.
Who Should Seriously Consider an ASX Listing?
An ASX reverse takeover is not the right path for every company. Candidates that tend to benefit most share a few characteristics: they are profitable or near-profitable, they have some existing commercial traction in the Asia-Pacific region (or seek it), and they are operating in a sector where Australian institutional and retail investors have demonstrated appetite — resources, technology, biotech, and certain consumer categories have historically fit that profile.
Founders should also honestly assess whether the ongoing compliance costs and the reality of trading in a different time zone align with their investor-relations capacity. Those who have not yet determined whether going public is right at all should work through that question before evaluating where to list.
For companies that are ready, the sell-side preparation process — building clean financials, organizing corporate documents, and preparing investor materials — looks broadly similar regardless of which exchange you target. Starting that preparation early is almost always the right move.
Frequently Asked Questions
Is an ASX reverse takeover recognized as a legitimate public offering by U.S. investors?
Yes, in principle. A company listed on the ASX is a publicly traded entity subject to Australian securities law. U.S. institutional investors can hold ASX-listed shares, though the practical accessibility depends on whether the company also files with the SEC or uses ADR programs. For founders whose primary investor base is domestic, an ASX listing may limit near-term U.S. institutional participation.
How do the costs of an ASX RTO compare to a U.S. alternative offering?
The original analysis above notes that attorney, accountant, and consultant fees are generally lower in Australia, and the ongoing Sarbanes-Oxley compliance burden does not apply. That said, cross-border legal work — engaging both U.S. and Australian counsel — can partially offset those savings. Each transaction is different; any cost comparison should be built on specific quotes, not general rules.
What are the biggest risks of going public on a foreign exchange?
The primary risks are market liquidity (smaller exchanges can produce thin trading volumes), investor familiarity (U.S. retail and institutional investors may not follow ASX-listed names), and regulatory complexity (operating under two sets of securities rules if the company remains domiciled in the United States). Companies with scalable revenues and a clear growth narrative tend to manage these risks better than early-stage businesses.
Where can I learn more about the full process of taking a company public?
The detailed steps for taking a company public outline the general sequence regardless of which exchange or structure is used. For businesses exploring their full range of options, comparing Reg A+, S-1, and reverse merger paths provides a useful framework before committing to any single route.
Considering a transaction?
Speak with our advisory team about your sell-side, buy-side, or capital needs — in confidence.